{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:22:03Z","timestamp":1791404523434,"version":"4.3.3"},"reference-count":427,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1074\/jbc.rev120.008207","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T20:45:33Z","timestamp":1605905133000},"page":"100105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":291,"special_numbering":"C","title":["The essential elements of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-1962","authenticated-orcid":false,"given":"Peng","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3479-2427","authenticated-orcid":false,"given":"Scott","family":"Ayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-9069","authenticated-orcid":false,"given":"Ashley I.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.REV120.008207_bib1","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/0006-291X(84)91209-9","article-title":"Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein","volume":"122","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib2","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","article-title":"Amyloid plaque Core protein in Alzheimer disease and down syndrome","volume":"82","author":"Masters","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib3","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1073\/pnas.83.11.4040","article-title":"Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau)","volume":"83","author":"Wood","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib4","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib5","article-title":"\u03b2-amyloid: the known unknowns","volume":"65","author":"Ayton","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1074\/jbc.REV120.008207_bib6","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer's disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1074\/jbc.REV120.008207_bib7","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.neuron.2015.02.010","article-title":"Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease","volume":"85","author":"Xia","year":"2015","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib8","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1073\/pnas.1618657114","article-title":"Analysis of 138 pathogenic mutations in presenilin-1 on the in\u00a0vitro production of A\u03b242 and\u00a0A\u03b240\u00a0peptides by \u03b3-secretase","volume":"114","author":"Sun","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm.2613","article-title":"Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export","volume":"18","author":"Lei","year":"2012","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.REV120.008207_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1326-9-29","article-title":"Motor and cognitive deficits in aged tau knockout mice in two background strains","volume":"9","author":"Lei","year":"2014","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.REV120.008207_bib11","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s13311-018-0656-x","article-title":"Marked age-related changes in brain iron homeostasis in amyloid protein precursor knockout mice","volume":"15","author":"Belaidi","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1074\/jbc.REV120.008207_bib12","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1523\/JNEUROSCI.5255-09.2010","article-title":"Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease?","volume":"30","author":"Adlard","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer's disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimers Dement. (N. Y.)"},{"key":"10.1074\/jbc.REV120.008207_bib14","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","article-title":"Randomized trial of verubecestat for prodromal Alzheimer's disease","volume":"380","author":"Egan","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1074\/jbc.REV120.008207_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1705971","article-title":"Trial of solanezumab for mild dementia due to Alzheimer's disease","volume":"378","author":"Honig","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1074\/jbc.REV120.008207_bib16","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease","volume":"370","author":"Doody","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1074\/jbc.REV120.008207_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1074\/jbc.REV120.008207_bib18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMe1714638","article-title":"Amyloid-beta solubility in the treatment of Alzheimer's disease","volume":"378","author":"Murphy","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1074\/jbc.REV120.008207_bib19","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ene.14484","article-title":"Unblinded by the light: ARIA in Alzheimer's clinical trials","volume":"28","author":"Gleason","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.410310310","article-title":"Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study","volume":"31","author":"Good","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.8073293","article-title":"Rapid induction of Alzheimer A\u03b2 amyloid formation by zinc","volume":"265","author":"Bush","year":"1994","journal-title":"Science"},{"key":"10.1074\/jbc.REV120.008207_bib22","doi-asserted-by":"crossref","first-page":"12817","DOI":"10.1074\/jbc.273.21.12817","article-title":"Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis","volume":"273","author":"Atwood","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib23","doi-asserted-by":"crossref","first-page":"37111","DOI":"10.1074\/jbc.274.52.37111","article-title":"Cu(II) potentiation of Alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction","volume":"274","author":"Huang","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib24","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1074\/jbc.274.33.23223","article-title":"Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion","volume":"274","author":"Cherny","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0891-5849(00)00494-9","article-title":"Redox-active iron mediates amyloid-beta toxicity","volume":"30","author":"Rottkamp","year":"2001","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib26","doi-asserted-by":"crossref","first-page":"40302","DOI":"10.1074\/jbc.M206428200","article-title":"Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2)","volume":"277","author":"Opazo","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib27","first-page":"1180","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nature"},{"key":"10.1074\/jbc.REV120.008207_bib28","doi-asserted-by":"crossref","first-page":"28097","DOI":"10.1074\/jbc.M115.680090","article-title":"Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis","volume":"290","author":"Chen","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1369\/jhc.4R6460.2005","article-title":"Zinc-specific autometallographic in\u00a0vivo selenium methods: tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells","volume":"53","author":"Danscher","year":"2005","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1074\/jbc.REV120.008207_bib30","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/308736a0","article-title":"Stimulation-induced uptake and release of zinc in hippocampal slices","volume":"308","author":"Howell","year":"1984","journal-title":"Nature"},{"key":"10.1074\/jbc.REV120.008207_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0896-6273(00)81149-6","article-title":"The actions of synaptically released zinc at hippocampal mossy fiber synapses","volume":"26","author":"Vogt","year":"2000","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.neuron.2011.07.019","article-title":"Vesicular zinc promotes presynaptic and inhibits postsynaptic long-term potentiation of mossy fiber-CA3 synapse","volume":"71","author":"Pan","year":"2011","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib33","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/s41380-020-0800-y","article-title":"Alzheimer risk factors age and female sex induce cortical A\u03b2 aggregation by raising extracellular zinc","volume":"25","author":"Datki","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13041-019-0528-2","article-title":"Zinc transporters in Alzheimer's disease","volume":"12","author":"Xu","year":"2019","journal-title":"Mol. Brain"},{"key":"10.1074\/jbc.REV120.008207_bib35","doi-asserted-by":"crossref","first-page":"14934","DOI":"10.1073\/pnas.93.25.14934","article-title":"ZnT-3, a putative transporter of zinc into synaptic vesicles","volume":"93","author":"Palmiter","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib36","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/359322a0","article-title":"Amyloid beta-peptide is produced by cultured cells during normal metabolism","volume":"359","author":"Haass","year":"1992","journal-title":"Nature"},{"key":"10.1074\/jbc.REV120.008207_bib37","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1016\/S0021-9258(17)32694-7","article-title":"Modulation of A\u03b2 adhesiveness and secretase site cleavage by zinc","volume":"269","author":"Bush","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1471-4159.2000.0751219.x","article-title":"Characterization of copper interactions with Alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42","volume":"75","author":"Atwood","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib39","doi-asserted-by":"crossref","first-page":"11734","DOI":"10.1002\/anie.201704615","article-title":"A\u00a0binuclear zinc interaction fold discovered in the homodimer of Alzheimer's amyloid-beta fragment with Taiwanese mutation D7H","volume":"56","author":"Polshakov","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1074\/jbc.REV120.008207_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fnmol.2018.00302","article-title":"Phosphorylation of the amyloid-beta peptide inhibits zinc-dependent aggregation, prevents Na,K-ATPase inhibition, and reduces cerebral plaque deposition","volume":"11","author":"Barykin","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00005072-198107000-00009","article-title":"The structure of neuritic plaque in the cerebral cortex of aged rats","volume":"40","author":"Vaughan","year":"1981","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib42","doi-asserted-by":"crossref","first-page":"16109","DOI":"10.1016\/S0021-9258(19)85394-2","article-title":"A\u00a0novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease","volume":"268","author":"Bush","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib43","doi-asserted-by":"crossref","first-page":"26618","DOI":"10.1016\/S0021-9258(18)47062-7","article-title":"The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily","volume":"269","author":"Bush","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib44","doi-asserted-by":"crossref","first-page":"11169","DOI":"10.1523\/JNEUROSCI.4704-12.2013","article-title":"Palmitoylation of amyloid precursor protein regulates amyloidogenic processing in lipid rafts","volume":"33","author":"Bhattacharyya","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166400","article-title":"Palmitoylated APP forms dimers, cleaved by BACE1","volume":"11","author":"Bhattacharyya","year":"2016","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib46","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.272.42.26464","article-title":"Zinc-induced Alzheimer's Abeta1-40 aggregation is mediated by conformational factors","volume":"272","author":"Huang","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib47","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00775-004-0602-8","article-title":"Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer's Abeta peptides","volume":"9","author":"Huang","year":"2004","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib48","doi-asserted-by":"crossref","first-page":"10355","DOI":"10.1021\/jp504779m","article-title":"Zn(2+) effect on structure and residual hydrophobicity of amyloid beta-peptide monomers","volume":"118","author":"Shi","year":"2014","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1074\/jbc.REV120.008207_bib49","doi-asserted-by":"crossref","first-page":"24414","DOI":"10.1074\/jbc.M602363200","article-title":"Distinct early folding and aggregation properties of Alzheimer amyloid-beta peptides Abeta40 and Abeta42: stable trimer or tetramer formation by Abeta42","volume":"281","author":"Chen","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib50","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1021\/bi7000032","article-title":"Metal ions differentially influence the aggregation and deposition of Alzheimer's beta-amyloid on a solid template","volume":"46","author":"Ha","year":"2007","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib51","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/j.1471-4159.2009.06269.x","article-title":"Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators","volume":"110","author":"T\u00f5ugu","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib52","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1073\/pnas.0913114107","article-title":"Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states","volume":"107","author":"Miller","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib53","article-title":"Amyloid-beta (Abeta) D7H mutation increases oligomeric Abeta42 and alters properties of Abeta-zinc\/copper assemblies","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib54","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1038\/s41598-018-23122-x","article-title":"Zinc ion rapidly induces toxic, off-pathway amyloid-beta oligomers distinct from amyloid-beta derived diffusible ligands in Alzheimer's disease","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.REV120.008207_bib55","doi-asserted-by":"crossref","first-page":"19439","DOI":"10.1074\/jbc.C000165200","article-title":"Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc","volume":"275","author":"Cuajungco","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1074\/jbc.REV120.008207_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/01.wnl.0000223644.08653.b5","article-title":"Elevated cortical zinc in Alzheimer disease","volume":"67","author":"Religa","year":"2006","journal-title":"Neurology"},{"key":"10.1074\/jbc.REV120.008207_bib58","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.neuroscience.2007.09.025","article-title":"Amyloid plaques arise from zinc-enriched cortical layers in APP\/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency","volume":"150","author":"Stoltenberg","year":"2007","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.REV120.008207_bib59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acschemneuro.6b00362","article-title":"Iron, copper, and zinc concentration in abeta plaques in the APP\/PS1 mouse model of Alzheimer's disease correlates with metal levels in the surrounding neuropil","volume":"8","author":"James","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/866da844-12ad-4fef-a57e-92a4549e035c","article-title":"The zinc dyshomeostasis hypothesis of Alzheimer's disease","volume":"7","author":"Craddock","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib61","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.neuroscience.2009.01.063","article-title":"Distribution and progression of amyloid-beta deposits in the amygdala of the aged macaque monkey, and parallels with zinc distribution","volume":"159","author":"Ichinohe","year":"2009","journal-title":"Neuroscience"},{"key":"10.1074\/jbc.REV120.008207_bib62","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib63","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1073\/pnas.092034699","article-title":"Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib64","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.0297-04.2004","article-title":"Neuronal zinc exchange with the blood vessel wall promotes cerebral amyloid angiopathy in an animal model of Alzheimer's disease","volume":"24","author":"Friedlich","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib65","first-page":"358","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"45","author":"Ayton","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib66","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1074\/jbc.M309730200","article-title":"Estrogen decreases zinc transporter 3 expression and synaptic vesicle zinc levels in mouse brain","volume":"279","author":"Lee","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib67","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib68","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2009-1063","article-title":"Clioquinol decreases amyloid-beta burden and reduces working memory impairment in a transgenic mouse model of Alzheimer's disease","volume":"17","author":"Grossi","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib69","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib70","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib71","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib72","first-page":"981","article-title":"Erratum: safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"8","author":"Lannfelt","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib73","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.trci.2017.10.001","article-title":"A\u00a0randomized, exploratory molecular imaging study targeting amyloid beta with a novel 8-OH quinoline in Alzheimer's disease: the PBT2-204 IMAGINE study","volume":"3","author":"Villemagne","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1074\/jbc.REV120.008207_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017669","article-title":"Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease","volume":"6","author":"Adlard","year":"2011","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib75","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1471-4159.2011.07402.x","article-title":"The Alzheimer's therapeutic PBT2 promotes amyloid-\u03b2 degradation and GSK3 phosphorylation via a metal chaperone activity","volume":"119","author":"Crouch","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib76","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1750-1326-6-65","article-title":"Amyloid beta protein-induced zinc sequestration leads to synaptic loss via dysregulation of the ProSAP2\/Shank3 scaffold","volume":"6","author":"Grabrucker","year":"2011","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.REV120.008207_bib77","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1523\/JNEUROSCI.5980-08.2009","article-title":"A\u00a0role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses","volume":"29","author":"Deshpande","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib78","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fnmol.2017.00456","article-title":"Zinc binding to S100B affords regulation of trace metal homeostasis and excitotoxicity in the brain","volume":"10","author":"Hagmeyer","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jnc.13760","article-title":"Amyloid beta attenuates metabotropic zinc sensing receptor, mZnR\/GPR39, dependent Ca(2+) , ERK1\/2 and Clusterin signaling in neurons","volume":"139","author":"Abramovitch-Dahan","year":"2016","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib80","doi-asserted-by":"crossref","first-page":"7168","DOI":"10.1038\/ncomms8168","article-title":"Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation","volume":"6","author":"Lee","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jagp.2014.05.001","article-title":"Depression and synaptic zinc regulation in Alzheimer disease, dementia with Lewy bodies, and Parkinson disease dementia","volume":"23","author":"Whitfield","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib82","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.neurobiolaging.2014.06.015","article-title":"Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment","volume":"35","author":"Whitfield","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib83","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/s41467-019-09613-z","article-title":"Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age","volume":"10","author":"Wingo","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib84","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.nbd.2014.12.012","article-title":"Metal chaperones prevent zinc-mediated cognitive decline","volume":"81","author":"Adlard","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.REV120.008207_bib85","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/acel.12178","article-title":"A\u00a0novel approach to rapidly prevent age-related cognitive decline","volume":"13","author":"Adlard","year":"2014","journal-title":"Aging Cell"},{"key":"10.1074\/jbc.REV120.008207_bib86","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3233\/JAD-140684","article-title":"Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies","volume":"42","author":"Graham","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib87","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0165-0270(97)00079-4","article-title":"Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains: a proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material","volume":"76","author":"Danscher","year":"1997","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1074\/jbc.REV120.008207_bib88","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pneurobio.2011.05.001","article-title":"Iron, zinc and copper in the Alzheimer's disease brain: a quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion","volume":"94","author":"Schrag","year":"2011","journal-title":"Prog. Neurobiol."},{"key":"10.1074\/jbc.REV120.008207_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(01)00672-4","article-title":"Determination of cadmium and zinc in Alzheimer's brain tissue using inductively coupled plasma mass spectrometry","volume":"195","author":"Panayi","year":"2002","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1074\/jbc.REV120.008207_bib90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3233\/JAD-2009-1162","article-title":"The effects of enhanced zinc on spatial memory and plaque formation in transgenic mice","volume":"18","author":"Linkous","year":"2009","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib91","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fnagi.2014.00174","article-title":"Spatial memory deficits in a mouse model of late-onset Alzheimer's disease are caused by zinc supplementation and correlate with amyloid-beta levels","volume":"6","author":"Flinn","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib92","doi-asserted-by":"crossref","first-page":"e15349","DOI":"10.1371\/journal.pone.0015349","article-title":"Zinc overload enhances APP cleavage and Abeta deposition in the Alzheimer mouse brain","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib93","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1440-1789.2011.01274.x","article-title":"Long-term oral intake of aluminium or zinc does not accelerate Alzheimer pathology in AbetaPP and AbetaPP\/tau transgenic mice","volume":"32","author":"Akiyama","year":"2012","journal-title":"Neuropathology"},{"key":"10.1074\/jbc.REV120.008207_bib94","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1515\/BC.2011.084","article-title":"Toxicity of Alzheimer's disease-associated Abeta peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability","volume":"392","author":"Hua","year":"2011","journal-title":"Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib95","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbr.2017.07.007","article-title":"Supplementation with zinc in rats enhances memory and reverses an age-dependent increase in plasma copper","volume":"333","author":"Sandusky-Beltran","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib96","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1038\/cddis.2010.73","article-title":"Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction","volume":"1","author":"Corona","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1074\/jbc.REV120.008207_bib97","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1179\/1476830512Y.0000000010","article-title":"Zinc diet and Alzheimer's disease: a systematic review","volume":"15","author":"Loef","year":"2012","journal-title":"Nutr. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib98","doi-asserted-by":"crossref","first-page":"863","DOI":"10.3233\/JAD-2012-112105","article-title":"Zinc transporter mRNA levels in Alzheimer's disease postmortem brain","volume":"29","author":"Beyer","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065475","article-title":"Altered expression of ZnT10 in Alzheimer's disease brain","volume":"8","author":"Bosomworth","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib100","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1750-3639.2009.00283.x","article-title":"Alterations of zinc transporter proteins ZnT-1, ZnT-4 and ZnT-6 in preclinical Alzheimer's disease brain","volume":"20","author":"Lyubartseva","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1074\/jbc.REV120.008207_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuro.2005.05.009","article-title":"4-Hydroxynonenal disrupts zinc export in primary rat cortical cells","volume":"27","author":"Smith","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1074\/jbc.REV120.008207_bib102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0896-6273(91)90272-2","article-title":"The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein","volume":"7","author":"Uchida","year":"1991","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0006-8993(00)03196-6","article-title":"Metallothionein III is reduced in Alzheimer's disease","volume":"894","author":"Yu","year":"2001","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib104","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1002\/j.1460-2075.1992.tb05590.x","article-title":"Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease","volume":"11","author":"Tsuji","year":"1992","journal-title":"EMBO J."},{"key":"10.1074\/jbc.REV120.008207_bib105","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1073\/pnas.96.7.3922","article-title":"Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease","volume":"96","author":"Lammich","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib106","doi-asserted-by":"crossref","first-page":"5544","DOI":"10.1111\/j.1742-4658.2005.04950.x","article-title":"In\u00a0vitro gamma-secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc","volume":"272","author":"Hoke","year":"2005","journal-title":"FEBS J."},{"key":"10.1074\/jbc.REV120.008207_bib107","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1074\/jbc.M116.754101","article-title":"Zinc and copper differentially modulate amyloid precursor protein processing by gamma-secretase and amyloid-beta peptide production","volume":"292","author":"Gerber","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib108","doi-asserted-by":"crossref","first-page":"9776","DOI":"10.1074\/jbc.M110.163964","article-title":"Presenilins promote the cellular uptake of copper and zinc and maintain copper chaperone of SOD1-dependent copper\/zinc superoxide dismutase activity","volume":"286","author":"Greenough","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib109","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2015.06.016","article-title":"Zinc affects the proteolytic stability of Apolipoprotein E in an isoform-dependent way","volume":"81","author":"Xu","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.REV120.008207_bib110","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10534-010-9354-9","article-title":"Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain","volume":"23","author":"Lee","year":"2010","journal-title":"Biometals"},{"key":"10.1074\/jbc.REV120.008207_bib111","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1471-4159.2004.02948.x","article-title":"Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells","volume":"92","author":"An","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib112","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.febslet.2005.11.059","article-title":"P70 S6 kinase mediates tau phosphorylation and synthesis","volume":"580","author":"Pei","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1074\/jbc.REV120.008207_bib113","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/WNR.0b013e32834c0a2d","article-title":"Zinc stimulates tau S214 phosphorylation by the activation of Raf\/mitogen-activated protein kinase-kinase\/extracellular signal-regulated kinase pathway","volume":"22","author":"Kim","year":"2011","journal-title":"Neuroreport"},{"key":"10.1074\/jbc.REV120.008207_bib114","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1074\/jbc.M111.309070","article-title":"Synaptic released zinc promotes tau hyperphosphorylation by inhibition of protein phosphatase 2A (PP2A)","volume":"287","author":"Sun","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib115","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.neurobiolaging.2012.07.003","article-title":"Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation","volume":"34","author":"Xiong","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib116","doi-asserted-by":"crossref","first-page":"44795","DOI":"10.1074\/jbc.M408127200","article-title":"Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc","volume":"279","author":"Harris","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib117","doi-asserted-by":"crossref","first-page":"189246","DOI":"10.4061\/2011\/189246","article-title":"GSK-3 in neurodegenerative diseases","volume":"2011","author":"Lei","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib118","doi-asserted-by":"crossref","first-page":"34648","DOI":"10.1074\/jbc.M109.058883","article-title":"Low micromolar zinc accelerates the fibrillization of human tau via bridging of Cys-291 and Cys-322","volume":"284","author":"Mo","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib119","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.celrep.2014.06.047","article-title":"Zinc binding directly regulates tau toxicity independent of tau hyperphosphorylation","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1074\/jbc.REV120.008207_bib120","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3233\/JAD-180151","article-title":"Zinc exacerbates tau pathology in a tau mouse model","volume":"64","author":"Craven","year":"2018","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib121","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1330","article-title":"Neurodegenerative diseases and oxidative stress","volume":"3","author":"Barnham","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1074\/jbc.REV120.008207_bib122","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pneurobio.2014.01.002","article-title":"Metabolism and functions of copper in brain","volume":"116","author":"Scheiber","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1074\/jbc.REV120.008207_bib123","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1074\/jbc.M116.756163","article-title":"In\u00a0Vivo modeling of the pathogenic effect of copper transporter mutations that cause Menkes and Wilson diseases, motor neuropathy, and susceptibility to Alzheimer's disease","volume":"292","author":"Mercer","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib124","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.neurobiolaging.2007.10.012","article-title":"Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid","volume":"30","author":"Strozyk","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1523\/JNEUROSCI.3699-04.2005","article-title":"NMDA receptor activation mediates copper homeostasis in hippocampal neurons","volume":"25","author":"Schlief","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib126","doi-asserted-by":"crossref","first-page":"14919","DOI":"10.1073\/pnas.0605390103","article-title":"Role of the Menkes copper-transporting ATPase in NMDA receptor-mediated neuronal toxicity","volume":"103","author":"Schlief","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib127","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/(SICI)1098-1063(1997)7:6<666::AID-HIPO8>3.0.CO;2-C","article-title":"Suppression of long-term potentiation in hippocampal slices by copper","volume":"7","author":"Doreulee","year":"1997","journal-title":"Hippocampus"},{"key":"10.1074\/jbc.REV120.008207_bib128","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1471-4159.2011.07417.x","article-title":"Biphasic effects of copper on neurotransmission in rat hippocampal neurons","volume":"119","author":"Peters","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib129","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/j.1460-9568.1996.tb01189.x","article-title":"Copper modulation of NMDA responses in mouse and rat cultured hippocampal neurons","volume":"8","author":"Vlachova","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib130","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1152\/jn.1996.76.4.2536","article-title":"Differential modulation by zinc and copper of amino acid receptors from rat olfactory bulb neurons","volume":"76","author":"Trombley","year":"1996","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1074\/jbc.REV120.008207_bib131","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-8993(96)01009-8","article-title":"The effects of copper ions on glutamate receptors in cultured rat cortical neurons","volume":"742","author":"Weiser","year":"1996","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib132","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0022-510X(96)00203-1","article-title":"Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress","volume":"143","author":"Deibel","year":"1996","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1074\/jbc.REV120.008207_bib133","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.neulet.2007.02.077","article-title":"Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias","volume":"418","author":"Magaki","year":"2007","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.REV120.008207_bib134","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1039\/C7MT00074J","article-title":"Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia","volume":"9","author":"Xu","year":"2017","journal-title":"Metallomics"},{"key":"10.1074\/jbc.REV120.008207_bib135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02796622","article-title":"Trace elements in the human central nervous system studied with neutron activation analysis","volume":"13","author":"Plantin","year":"1987","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1074\/jbc.REV120.008207_bib136","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2011.10.446","article-title":"Elevated labile Cu is associated with oxidative pathology in Alzheimer disease","volume":"52","author":"James","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib137","first-page":"623241","article-title":"Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction","volume":"2013","author":"Rembach","year":"2013","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib138","doi-asserted-by":"crossref","first-page":"14187","DOI":"10.1073\/pnas.2332818100","article-title":"Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice","volume":"100","author":"Bayer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib139","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1074\/jbc.M110.128512","article-title":"Copper promotes the trafficking of the amyloid precursor protein","volume":"286","author":"Acevedo","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib140","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1042\/BJ20080103","article-title":"Intracellular copper deficiency increases amyloid-beta secretion by diverse mechanisms","volume":"412","author":"Cater","year":"2008","journal-title":"Biochem. J."},{"key":"10.1074\/jbc.REV120.008207_bib141","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1021\/bi900290c","article-title":"Cellular copper import by nanocarrier systems, intracellular availability, and effects on amyloid beta peptide secretion","volume":"48","author":"Treiber","year":"2009","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib142","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12502","article-title":"Copper chelators promote nonamyloidogenic processing of AbetaPP via MT1\/2\/CREB-dependent signaling pathways in AbetaPP\/PS1 transgenic mice","volume":"65","author":"Wang","year":"2018","journal-title":"J.\u00a0Pineal Res."},{"key":"10.1074\/jbc.REV120.008207_bib143","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/bj3440461","article-title":"Copper inhibits beta-amyloid production and stimulates the non-amyloidogenic pathway of amyloid-precursor-protein secretion","volume":"344 Pt 2","author":"Borchardt","year":"1999","journal-title":"Biochem. J."},{"key":"10.1074\/jbc.REV120.008207_bib144","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3233\/JAD-2010-100717","article-title":"Deficiency of the copper chaperone for superoxide dismutase increases amyloid-beta production","volume":"21","author":"Gray","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib145","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1126\/science.271.5254.1406","article-title":"The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)","volume":"271","author":"Multhaup","year":"1996","journal-title":"Science"},{"key":"10.1074\/jbc.REV120.008207_bib146","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1523\/JNEUROSCI.19-21-09170.1999","article-title":"The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures","volume":"19","author":"White","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib147","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1039\/C3MT00258F","article-title":"Quantification of copper binding to amyloid precursor protein domain 2 and its Caenorhabditis elegans ortholog. Implications for biological function","volume":"6","author":"Leong","year":"2014","journal-title":"Metallomics"},{"key":"10.1074\/jbc.REV120.008207_bib148","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1021\/acs.biochem.8b00572","article-title":"The human amyloid precursor protein binds copper ions dominated by a picomolar-affinity site in the helix-rich E2 domain","volume":"57","author":"Young","year":"2018","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib149","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.M400805200","article-title":"Copper depletion down-regulates expression of the Alzheimer's disease amyloid-beta precursor protein gene","volume":"279","author":"Bellingham","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib150","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(99)01861-2","article-title":"Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice","volume":"842","author":"White","year":"1999","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib151","doi-asserted-by":"crossref","first-page":"44670","DOI":"10.1074\/jbc.M204379200","article-title":"Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron","volume":"277","author":"Maynard","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib152","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1471-4159.2004.02731.x","article-title":"Gene knockout of amyloid precursor protein and amyloid precursor-like protein-2 increases cellular copper levels in primary mouse cortical neurons and embryonic fibroblasts","volume":"91","author":"Bellingham","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib153","doi-asserted-by":"crossref","first-page":"11007","DOI":"10.1074\/jbc.M113.538710","article-title":"Phosphorylation of amyloid precursor protein at threonine 668 is essential for its copper-responsive trafficking in SH-SY5Y neuroblastoma cells","volume":"289","author":"Acevedo","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib154","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsb.2005.09.004","article-title":"Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease","volume":"155","author":"Miller","year":"2006","journal-title":"J.\u00a0Struct. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib155","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.neuroimage.2009.05.063","article-title":"Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease","volume":"47","author":"Lanzirotti","year":"2009","journal-title":"Neuroimage"},{"key":"10.1074\/jbc.REV120.008207_bib156","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1021\/bi0272151","article-title":"Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence","volume":"42","author":"Dong","year":"2003","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib157","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1360\/042004-93","article-title":"Molecular modeling of the inhibitory mechanism of copper(II) on aggregation of amyloid beta-peptide","volume":"48","author":"Jiao","year":"2005","journal-title":"Sci. China Ser. B"},{"key":"10.1074\/jbc.REV120.008207_bib158","doi-asserted-by":"crossref","first-page":"7646","DOI":"10.1021\/jp0673359","article-title":"Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation","volume":"111","author":"Jiao","year":"2007","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1074\/jbc.REV120.008207_bib159","doi-asserted-by":"crossref","first-page":"16663","DOI":"10.1021\/ja907045h","article-title":"Small molecule modulators of copper-induced Abeta aggregation","volume":"131","author":"Hindo","year":"2009","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1074\/jbc.REV120.008207_bib160","doi-asserted-by":"crossref","first-page":"4994","DOI":"10.1021\/ja100943r","article-title":"A\u00a0prochelator activated by beta-secretase inhibits Abeta aggregation and suppresses copper-induced reactive oxygen species formation","volume":"132","author":"Folk","year":"2010","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1074\/jbc.REV120.008207_bib161","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jinorgbio.2014.04.011","article-title":"8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Abeta peptide aggregation","volume":"139","author":"Gomes","year":"2014","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1074\/jbc.REV120.008207_bib162","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/cmdc.201700734","article-title":"Preparation of tetradentate copper chelators as potential anti-Alzheimer agents","volume":"13","author":"Zhang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1074\/jbc.REV120.008207_bib163","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1021\/ic4003059","article-title":"Role of metal ions in the self-assembly of the Alzheimer's amyloid-beta peptide","volume":"52","author":"Faller","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib164","doi-asserted-by":"crossref","first-page":"26952","DOI":"10.1074\/jbc.M111.220863","article-title":"Cu(II) mediates kinetically distinct, non-amyloidogenic aggregation of amyloid-beta peptides","volume":"286","author":"Pedersen","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib165","doi-asserted-by":"crossref","first-page":"11192","DOI":"10.1021\/ic201739n","article-title":"pH-Dependent Cu(II) coordination to amyloid-beta peptide: impact of sequence alterations, including the H6R and D7N familial mutations","volume":"50","author":"Alies","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib166","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1002\/anie.200904567","article-title":"Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1-16 amyloid-beta peptide: a key role of the first two N-terminus residues","volume":"48","author":"Dorlet","year":"2009","journal-title":"Angew. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib167","doi-asserted-by":"crossref","first-page":"18169","DOI":"10.1074\/jbc.M313572200","article-title":"Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques","volume":"279","author":"Syme","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib168","doi-asserted-by":"crossref","first-page":"9260","DOI":"10.1021\/ja046032u","article-title":"NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease","volume":"128","author":"Hou","year":"2006","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1074\/jbc.REV120.008207_bib169","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/anie.201410389","article-title":"Multi-frequency, multi-technique pulsed EPR investigation of the copper binding site of murine amyloid beta peptide","volume":"54","author":"Kim","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1074\/jbc.REV120.008207_bib170","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/cbic.201600255","article-title":"Kinetics of the interactions between copper and amyloid-beta with FAD mutations and phosphorylation at the N terminus","volume":"17","author":"Girvan","year":"2016","journal-title":"ChemBioChem"},{"key":"10.1074\/jbc.REV120.008207_bib171","doi-asserted-by":"crossref","first-page":"6294","DOI":"10.1021\/acs.inorgchem.9b00507","article-title":"X-ray absorption spectroscopy investigations of copper(II) coordination in the human amyloid beta peptide","volume":"58","author":"Summers","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib172","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/anie.201005838","article-title":"Copper(II) coordination to amyloid beta: murine versus human peptide","volume":"50","author":"Eury","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1074\/jbc.REV120.008207_bib173","doi-asserted-by":"crossref","first-page":"16190","DOI":"10.1038\/s41598-018-33935-5","article-title":"Copper redox cycling inhibits abeta fibre formation and promotes fibre fragmentation, while generating a dityrosine abeta dimer","volume":"8","author":"Gu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.REV120.008207_bib174","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1523\/JNEUROSCI.1774-19.2020","article-title":"Neuronal glutamatergic synaptic clefts alkalinize rather than acidify during neurotransmission","volume":"40","author":"Stawarski","year":"2020","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib175","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1021\/bi990438f","article-title":"The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction","volume":"38","author":"Huang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib176","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1021\/bi700508n","article-title":"Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance","volume":"46","author":"Jiang","year":"2007","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib177","doi-asserted-by":"crossref","first-page":"17113","DOI":"10.1073\/pnas.1011315107","article-title":"Electrochemical and homogeneous electron transfers to the Alzheimer amyloid-beta copper complex follow a preorganization mechanism","volume":"107","author":"Balland","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib178","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/anie.201508597","article-title":"Free superoxide is an intermediate in the production of H2O2 by copper(I)-Abeta peptide and O2","volume":"55","author":"Reybier","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1074\/jbc.REV120.008207_bib179","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1172\/JCI23610","article-title":"Alzheimer disease \u03b2-amyloid activity mimics cholesterol oxidase","volume":"115","author":"Puglielli","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1074\/jbc.REV120.008207_bib180","doi-asserted-by":"crossref","first-page":"31657","DOI":"10.1074\/jbc.M804722200","article-title":"Sequestration of copper from beta-amyloid promotes selective lysis by cyclen-hybrid cleavage agents","volume":"283","author":"Wu","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib181","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/cbic.200900474","article-title":"Copper transfer from Cu-Abeta to human serum albumin inhibits aggregation, radical production and reduces Abeta toxicity","volume":"11","author":"Perrone","year":"2010","journal-title":"ChemBioChem"},{"key":"10.1074\/jbc.REV120.008207_bib182","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2012.11.019","article-title":"Apigenin attenuates copper-mediated beta-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model","volume":"1492","author":"Zhao","year":"2013","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib183","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1021\/acschemneuro.6b00145","article-title":"Tripeptide GGH as the inhibitor of copper-amyloid-beta-mediated redox reaction and toxicity","volume":"7","author":"Hu","year":"2016","journal-title":"ACS Chem. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib184","doi-asserted-by":"crossref","first-page":"20466","DOI":"10.1074\/jbc.M100175200","article-title":"Alzheimer's disease amyloid-beta binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits","volume":"276","author":"Curtain","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib185","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1074\/jbc.M205455200","article-title":"Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid","volume":"278","author":"Curtain","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib186","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/bi0358824","article-title":"Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta","volume":"43","author":"Atwood","year":"2004","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib187","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1096\/fj.04-1890fje","article-title":"Tyrosine gated electron transfer is key to the toxic mechanism of Alzheimer's disease beta-amyloid","volume":"18","author":"Barnham","year":"2004","journal-title":"FASEB J."},{"key":"10.1074\/jbc.REV120.008207_bib188","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-61779-551-0_1","article-title":"Rapid generation of dityrosine cross-linked A\u03b2 oligomers via Cu-redox cycling","volume":"849","author":"Gunn","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib189","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/tx025666g","article-title":"Dityrosine cross-linked Abeta peptides: fibrillar beta-structure in Abeta(1-40) is conducive to formation of dityrosine cross-links but a dityrosine cross-link in Abeta(8-14) does not induce beta-structure","volume":"16","author":"Yoburn","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1074\/jbc.REV120.008207_bib190","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1021\/bi0620961","article-title":"Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide","volume":"46","author":"Smith","year":"2007","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib191","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1021\/acs.analchem.7b00941","article-title":"Characterization and identification of dityrosine cross-linked peptides using tandem mass spectrometry","volume":"89","author":"Mukherjee","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib192","doi-asserted-by":"crossref","first-page":"6134","DOI":"10.1074\/jbc.M115.655183","article-title":"Amyloid-\u03b2 peptide A\u03b23pE-42 induces lipid peroxidation, membrane permeabilization, and calcium influx in neurons","volume":"291","author":"Gunn","year":"2016","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib193","doi-asserted-by":"crossref","first-page":"062107","DOI":"10.1088\/1742-6596\/1294\/6\/062107","article-title":"The involvement of dityrosine crosslinks in lipofuscin accumulation in Alzheimer\u2019s disease","volume":"1294","author":"Al-Hilaly","year":"2019","journal-title":"J.\u00a0Phys. Conf. Ser."},{"key":"10.1074\/jbc.REV120.008207_bib194","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.freeradbiomed.2010.01.030","article-title":"Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells","volume":"48","author":"H\u00f6hn","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib195","doi-asserted-by":"crossref","first-page":"42959","DOI":"10.1074\/jbc.M305494200","article-title":"Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation","volume":"278","author":"Barnham","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib196","doi-asserted-by":"crossref","first-page":"42528","DOI":"10.1074\/jbc.M406465200","article-title":"Enhanced toxicity and cellular binding of a modified amyloid beta peptide with a methionine to valine substitution","volume":"279","author":"Ciccotosto","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib197","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/psc.626","article-title":"Methionine regulates copper\/hydrogen peroxide oxidation products of Abeta","volume":"11","author":"Ali","year":"2005","journal-title":"J.\u00a0Pept. Sci."},{"key":"10.1074\/jbc.REV120.008207_bib198","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jinorgbio.2018.10.005","article-title":"Nitration of amyloid-beta peptide (1-42) as a protective mechanism for the amyloid-beta peptide (1-42) against copper ion toxicity","volume":"190","author":"Zhao","year":"2019","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1074\/jbc.REV120.008207_bib199","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1326-4-2","article-title":"Intracellular amyloid formation in muscle cells of Abeta-transgenic Caenorhabditis elegans: determinants and physiological role in copper detoxification","volume":"4","author":"Minniti","year":"2009","journal-title":"Mol. Neurodegener"},{"key":"10.1074\/jbc.REV120.008207_bib200","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1523\/JNEUROSCI.0336-11.2011","article-title":"Copper reduces Abeta oligomeric species and ameliorates neuromuscular synaptic defects in a C. elegans model of inclusion body myositis","volume":"31","author":"Rebolledo","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib201","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1016\/j.neurobiolaging.2013.05.029","article-title":"Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Abeta42-induced Alzheimer's disease-like symptoms","volume":"34","author":"Lang","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib202","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3233\/JAD-2010-100408","article-title":"A\u00a0copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease","volume":"21","author":"Quinn","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib203","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043105","article-title":"Copper chelator induced efficient episodic memory recovery in a non-transgenic Alzheimer's mouse model","volume":"7","author":"Ceccom","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib204","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1039\/C7MT00075H","article-title":"Potentiating role of copper on spatial memory deficit induced by beta amyloid and evaluation of mitochondrial function markers in the hippocampus of rats","volume":"9","author":"Behzadfar","year":"2017","journal-title":"Metallomics"},{"key":"10.1074\/jbc.REV120.008207_bib205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2018.09.003","article-title":"Amyloidogenesis induced by diet cholesterol and copper in a model mouse for Alzheimer's disease and protection effects of zinc and fluvastatin","volume":"143","author":"Yao","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1074\/jbc.REV120.008207_bib206","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00204-018-2163-6","article-title":"Proteomic alterations of brain subcellular organelles caused by low-dose copper exposure: implication for Alzheimer's disease","volume":"92","author":"Yu","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1074\/jbc.REV120.008207_bib207","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2019.03.002","article-title":"Low-dose oral copper treatment changes the hippocampal phosphoproteomic profile and perturbs mitochondrial function in a mouse model of Alzheimer's disease","volume":"135","author":"Chen","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib208","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10571-009-9401-7","article-title":"Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice","volume":"29","author":"Maynard","year":"2009","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1074\/jbc.REV120.008207_bib209","doi-asserted-by":"crossref","first-page":"14193","DOI":"10.1073\/pnas.2332851100","article-title":"In\u00a0vivo reduction of amyloid-beta by a mutant copper transporter","volume":"100","author":"Phinney","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib210","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00702-008-0080-1","article-title":"Intake of copper has no effect on cognition in patients with mild Alzheimer\u2019s disease: a pilot phase 2 clinical trial","volume":"115","author":"Kessler","year":"2008","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1074\/jbc.REV120.008207_bib211","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062811","article-title":"Presenilin promotes dietary copper uptake","volume":"8","author":"Southon","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib212","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/j.1471-4159.2010.06888.x","article-title":"Altered microglial copper homeostasis in a mouse model of Alzheimer's disease","volume":"114","author":"Zheng","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib213","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.peptides.2005.09.002","article-title":"Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS","volume":"27","author":"Ma","year":"2006","journal-title":"Peptides"},{"key":"10.1074\/jbc.REV120.008207_bib214","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.bbrc.2007.04.191","article-title":"Hydrogen peroxide can be generated by tau in the presence of Cu(II)","volume":"358","author":"Su","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ab.2013.07.015","article-title":"Probing copper\/tau protein interactions electrochemically","volume":"442","author":"Martic","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1074\/jbc.REV120.008207_bib216","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1471-4159.2000.0740270.x","article-title":"In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals","volume":"74","author":"Sayre","year":"2000","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib217","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2047-9158-3-24","article-title":"Modulation of tau phosphorylation by environmental copper","volume":"3","author":"Voss","year":"2014","journal-title":"Transl. Neurodegener"},{"key":"10.1074\/jbc.REV120.008207_bib218","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1471-4159.2009.05901.x","article-title":"Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD","volume":"108","author":"Kitazawa","year":"2009","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib219","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainres.2009.11.085","article-title":"Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives","volume":"1319","author":"Arnal","year":"2010","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib220","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JAD-2010-101473","article-title":"Copper in Alzheimer's disease: a meta-analysis of serum,plasma, and cerebrospinal fluid studies","volume":"24","author":"Bucossi","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib221","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3233\/JAD-2010-101098","article-title":"Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals","volume":"23","author":"Squitti","year":"2011","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib222","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-121474","article-title":"Longitudinal analysis of serum copper and ceruloplasmin in Alzheimer's disease","volume":"34","author":"Rembach","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib223","doi-asserted-by":"crossref","first-page":"104810","DOI":"10.1016\/j.nbd.2020.104810","article-title":"Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying beta-amyloid pathology","volume":"139","author":"Diouf","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.REV120.008207_bib224","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1039\/c0cc01175d","article-title":"A\u00a0copper radiopharmaceutical for diagnostic imaging of Alzheimer's disease: a bis(thiosemicarbazonato)copper(II) complex that binds to amyloid-beta plaques","volume":"46","author":"Lim","year":"2010","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1074\/jbc.REV120.008207_bib225","doi-asserted-by":"crossref","first-page":"16120","DOI":"10.1021\/ja4057807","article-title":"Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Abeta plaques","volume":"135","author":"Hickey","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1074\/jbc.REV120.008207_bib226","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1021\/acs.inorgchem.8b03466","article-title":"Potential diagnostic imaging of Alzheimer's disease with copper-64 complexes that bind to amyloid-beta plaques","volume":"58","author":"McInnes","year":"2019","journal-title":"Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib227","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1002\/anie.201904047","article-title":"Activatable small-molecule photoacoustic probes that cross the blood-brain barrier for visualization of copper(II) in mice with Alzheimer's disease","volume":"58","author":"Wang","year":"2019","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1074\/jbc.REV120.008207_bib228","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1073\/pnas.0809057106","article-title":"Increasing Cu bioavailability inhibits Abeta oligomers and tau phosphorylation","volume":"106","author":"Crouch","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib229","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JAD-2010-1359","article-title":"Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease","volume":"20","author":"Fodero-Tavoletti","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib230","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2967\/jnumed.115.162370","article-title":"PET imaging of copper trafficking in a mouse model of Alzheimer disease","volume":"57","author":"Torres","year":"2016","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1074\/jbc.REV120.008207_bib231","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1039\/C7MT00227K","article-title":"Studies of copper trafficking in a mouse model of Alzheimer's disease by positron emission tomography: comparison of (64)Cu acetate and (64)CuGTSM","volume":"9","author":"Andreozzi","year":"2017","journal-title":"Metallomics."},{"key":"10.1074\/jbc.REV120.008207_bib232","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/bph.14881","article-title":"CuII(atsm) inhibits ferroptosis: implications for treatment of neurodegenerative disease","volume":"177","author":"Southon","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1074\/jbc.REV120.008207_bib233","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090070","article-title":"Neuroprotective copper bis(thiosemicarbazonato) complexes promote neurite elongation","volume":"9","author":"Bica","year":"2014","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib234","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00775-012-0949-1","article-title":"Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation","volume":"18","author":"Lambert","year":"2013","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib235","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1074\/jbc.M705957200","article-title":"Selective intracellular release of copper and zinc ions from bis(thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide","volume":"283","author":"Donnelly","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib236","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13311-016-0504-9","article-title":"The copper bis(thiosemicarbazone) complex CuII(atsm) is protective against cerebral ischemia through modulation of the inflammatory milieu","volume":"14","author":"Huuskonen","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1074\/jbc.REV120.008207_bib237","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1084\/jem.20112285","article-title":"The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's disease","volume":"209","author":"Hung","year":"2012","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1074\/jbc.REV120.008207_bib238","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/21678421.2013.824000","article-title":"Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis","volume":"14","author":"McAllum","year":"2013","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"10.1074\/jbc.REV120.008207_bib239","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnagi.2013.00034","article-title":"A\u00a0delicate balance: iron metabolism and diseases of the brain","volume":"5","author":"Hare","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib240","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/jnc.14621","article-title":"Iron-induced energy supply deficiency and mitochondrial fragmentation in neurons","volume":"147","author":"Huang","year":"2018","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib241","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41589-019-0394-3","article-title":"Axonal dispatch of iron in neuronal signaling","volume":"15","author":"Lei","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib242","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41589-019-0371-x","article-title":"Axonal iron transport in the brain modulates anxiety-related behaviors","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib243","doi-asserted-by":"crossref","first-page":"1468S","DOI":"10.1093\/jn\/133.5.1468S","article-title":"Iron deficiency alters brain development and functioning","volume":"133","author":"Beard","year":"2003","journal-title":"J.\u00a0Nutr."},{"key":"10.1074\/jbc.REV120.008207_bib244","doi-asserted-by":"crossref","first-page":"581256","DOI":"10.1155\/2014\/581256","article-title":"Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration","volume":"2014","author":"Ayton","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1074\/jbc.REV120.008207_bib245","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-981-13-9589-5_10","article-title":"Diagnostics and treatments of iron-related CNS diseases","volume":"1173","author":"Xiong","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib246","first-page":"101904","article-title":"Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE epsilon4, sex and age","author":"Ayton","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"10.1074\/jbc.REV120.008207_bib247","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-2012-120766","article-title":"Brain burdens of aluminum, iron, and copper and their relationships with amyloid-beta pathology in 60 human brains","volume":"31","author":"Exley","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib248","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuroimage.2016.05.057","article-title":"Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex","volume":"137","author":"Hare","year":"2016","journal-title":"NeuroImage"},{"key":"10.1074\/jbc.REV120.008207_bib249","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3233\/JAD-161143","article-title":"Cortical iron reflects severity of Alzheimer's disease","volume":"60","author":"van Duijn","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.neurobiolaging.2017.10.017","article-title":"Postmortem MRI and histology demonstrate differential iron accumulation and cortical myelin organization in early- and late-onset Alzheimer's disease","volume":"62","author":"Bulk","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib251","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.talanta.2019.01.056","article-title":"Laser ablation ICP-MS for simultaneous quantitative imaging of iron and ferroportin in hippocampus of human brain tissues with Alzheimer's disease","volume":"197","author":"Cruz-Alonso","year":"2019","journal-title":"Talanta"},{"key":"10.1074\/jbc.REV120.008207_bib252","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1039\/C3SC53461H","article-title":"An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta","volume":"5","author":"Hare","year":"2014","journal-title":"Chem. Sci."},{"key":"10.1074\/jbc.REV120.008207_bib253","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S000711451100376X","article-title":"Copper and iron in Alzheimer's disease: a systematic review and its dietary implications","volume":"107","author":"Loef","year":"2012","journal-title":"Br. J. Nutr."},{"key":"10.1074\/jbc.REV120.008207_bib254","doi-asserted-by":"crossref","first-page":"16440","DOI":"10.1038\/s41598-020-73324-5","article-title":"Effects of Alzheimer's disease and formalin fixation on the different mineralised-iron forms in the human brain","volume":"10","author":"van der Weerd","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.REV120.008207_bib255","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib256","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neuroimage.2019.02.019","article-title":"Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI","volume":"191","author":"Gong","year":"2019","journal-title":"NeuroImage"},{"key":"10.1074\/jbc.REV120.008207_bib257","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1038\/s41598-018-25021-7","article-title":"Quantitative comparison of different iron forms in the temporal cortex of Alzheimer patients and control subjects","volume":"8","author":"Bulk","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.REV120.008207_bib258","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.neuroimage.2014.11.010","article-title":"Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter","volume":"105","author":"Sun","year":"2015","journal-title":"NeuroImage"},{"key":"10.1074\/jbc.REV120.008207_bib259","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/0006-3223(94)90047-7","article-title":"In\u00a0vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI","volume":"35","author":"Bartzokis","year":"1994","journal-title":"Biol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib260","first-page":"821","article-title":"MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease","volume":"46","author":"Bartzokis","year":"2000","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"key":"10.1074\/jbc.REV120.008207_bib261","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-151037","article-title":"Patterns of brain iron accumulation in vascular dementia and Alzheimer's dementia using quantitative susceptibility mapping imaging","volume":"51","author":"Moon","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib262","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.neuroimage.2011.08.019","article-title":"High field magnetic resonance microscopy of the human hippocampus in Alzheimer's disease: quantitative imaging and correlation with iron","volume":"59","author":"Antharam","year":"2012","journal-title":"NeuroImage"},{"key":"10.1074\/jbc.REV120.008207_bib263","doi-asserted-by":"crossref","first-page":"e2586","DOI":"10.1212\/WNL.0000000000010868","article-title":"Contribution of iron and Abeta to age differences in entorhinal and hippocampal subfield volume","volume":"95","author":"Foster","year":"2020","journal-title":"Neurology"},{"key":"10.1074\/jbc.REV120.008207_bib264","doi-asserted-by":"crossref","first-page":"35514","DOI":"10.1038\/srep35514","article-title":"Colocalization of cerebral iron with amyloid beta in mild cognitive impairment","volume":"6","author":"van Bergen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.REV120.008207_bib265","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/brain\/awx137","article-title":"Cerebral quantitative susceptibility mapping predicts amyloid-beta-related cognitive decline","volume":"140","author":"Ayton","year":"2017","journal-title":"Brain"},{"key":"10.1074\/jbc.REV120.008207_bib266","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1021\/acschemneuro.8b00194","article-title":"Increased iron deposition on brain quantitative susceptibility mapping correlates with decreased cognitive function in Alzheimer's disease","volume":"9","author":"Du","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib267","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroimage.2018.03.021","article-title":"Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and beta-amyloid as an indicator of cognitive performance at high age","volume":"174","author":"van Bergen","year":"2018","journal-title":"NeuroImage"},{"key":"10.1074\/jbc.REV120.008207_bib268","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/brain\/awaa089","article-title":"Relationship between cortical iron and tau aggregation in Alzheimer's disease","volume":"143","author":"Spotorno","year":"2020","journal-title":"Brain"},{"key":"10.1074\/jbc.REV120.008207_bib269","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/ncomms7760","article-title":"Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE","volume":"6","author":"Ayton","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib270","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/jamaneurol.2016.4406","article-title":"Association of cerebrospinal fluid ferritin level with preclinical cognitive decline in APOE-epsilon4 carriers","volume":"74","author":"Ayton","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib271","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/jnnp-2017-316551","article-title":"Evidence that iron accelerates Alzheimer's pathology: a CSF biomarker study","volume":"89","author":"Ayton","year":"2018","journal-title":"J.\u00a0Neurol. Neurosurg. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib272","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.nbd.2018.12.010","article-title":"Cerebrospinal fluid ferritin levels predict brain hypometabolism in people with underlying beta-amyloid pathology","volume":"124","author":"Diouf","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.REV120.008207_bib273","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/mp.2013.178","article-title":"An anemia of Alzheimer's disease","volume":"19","author":"Faux","year":"2014","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib274","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/mp.2017.146","article-title":"Elevated plasma ferritin in elderly individuals with high neocortical amyloid-beta load","volume":"23","author":"Goozee","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib275","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/cn5003557","article-title":"Decreased plasma iron in Alzheimer's disease is due to transferrin desaturation","volume":"6","author":"Hare","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib276","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","article-title":"Deep multilayer brain proteomics identifies molecular networks in Alzheimer's disease progression","volume":"105","author":"Bai","year":"2020","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib277","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","article-title":"Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease","volume":"26","author":"Zhou","year":"2020","journal-title":"Nat. Med."},{"key":"10.1074\/jbc.REV120.008207_bib278","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1097\/00001756-199309000-00015","article-title":"Increased frequency of the transferrin C2 subtype in Alzheimer's disease","volume":"4","author":"van Rensburg","year":"1993","journal-title":"Neuroreport"},{"key":"10.1074\/jbc.REV120.008207_bib279","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.neurobiolaging.2006.08.009","article-title":"Genes related to iron metabolism and susceptibility to Alzheimer's disease in Basque population","volume":"28","author":"Blazquez","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib280","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.neurobiolaging.2007.05.026","article-title":"HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study","volume":"30","author":"Alizadeh","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib281","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.neurobiolaging.2010.07.018","article-title":"Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project","volume":"33","author":"Lehmann","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib282","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnagi.2013.00037","article-title":"Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases","volume":"5","author":"Mariani","year":"2013","journal-title":"Front. Aging Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib283","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193867","article-title":"Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases","volume":"13","author":"Tisato","year":"2018","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib284","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1046\/j.1471-4159.1995.65020710.x","article-title":"Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions","volume":"65","author":"Loeffler","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0304-3940(93)90805-U","article-title":"Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease","volume":"159","author":"Connor","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.REV120.008207_bib286","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jns.2010.08.047","article-title":"Case-control studies on ceruloplasmin and superoxide dismutase (SOD1) in neurodegenerative diseases: a short review","volume":"299","author":"Torsdottir","year":"2010","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1074\/jbc.REV120.008207_bib287","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.bbadis.2015.07.017","article-title":"Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients","volume":"1852","author":"Guerreiro","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.REV120.008207_bib288","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/2051-5960-1-55","article-title":"The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease","volume":"1","author":"Raha","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib289","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fnins.2018.00740","article-title":"The dual role of hepcidin in brain iron load and inflammation","volume":"12","author":"Vela","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib290","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.freeradbiomed.2020.07.012","article-title":"Astrocyte hepcidin ameliorates neuronal loss through attenuating brain iron deposition and oxidative stress in APP\/PS1 mice","volume":"158","author":"Xu","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib291","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.freeradbiomed.2012.10.558","article-title":"Metallostasis in Alzheimer's disease","volume":"62","author":"Ayton","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib292","doi-asserted-by":"crossref","first-page":"45518","DOI":"10.1074\/jbc.M207435200","article-title":"An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript","volume":"277","author":"Rogers","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib293","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1042\/BST0361282","article-title":"Iron and the translation of the amyloid precursor protein (APP) and ferritin mRNAs: riboregulation against neural oxidative damage in Alzheimer's disease","volume":"36","author":"Rogers","year":"2008","journal-title":"Biochem. Soc. Trans."},{"key":"10.1074\/jbc.REV120.008207_bib294","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065978","article-title":"Novel 5' untranslated region directed blockers of iron-regulatory protein-1 dependent amyloid precursor protein translation: implications for down syndrome and Alzheimer's disease","volume":"8","author":"Bandyopadhyay","year":"2013","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib295","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1471-4159.1995.64010307.x","article-title":"Iron levels modulate alpha-secretase cleavage of amyloid precursor protein","volume":"64","author":"Bodovitz","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib296","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.exer.2014.10.012","article-title":"Iron increases APP translation and amyloid-beta production in the retina","volume":"129","author":"Guo","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1074\/jbc.REV120.008207_bib297","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/aps.2017.113","article-title":"Iron dysregulates APP processing accompanying with sAPP\u03b1 cellular retention and \u03b2-secretase inhibition in rat cortical neurons","volume":"39","author":"Chen","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1074\/jbc.REV120.008207_bib298","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1096\/fj.09-135749","article-title":"Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation","volume":"23","author":"Zheng","year":"2009","journal-title":"FASEB J."},{"key":"10.1074\/jbc.REV120.008207_bib299","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","article-title":"Iron-export ferroxidase activity of \u03b2-amyloid precursor protein is inhibited by zinc in Alzheimer's disease","volume":"142","author":"Duce","year":"2010","journal-title":"Cell"},{"key":"10.1074\/jbc.REV120.008207_bib300","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/sj.emboj.7601735","article-title":"Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin","volume":"26","author":"De Domenico","year":"2007","journal-title":"EMBO J."},{"key":"10.1074\/jbc.REV120.008207_bib301","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114174","article-title":"beta-Amyloid precursor protein does not possess ferroxidase activity but does stabilize the cell surface ferrous iron exporter ferroportin","volume":"9","author":"Wong","year":"2014","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib302","doi-asserted-by":"crossref","first-page":"809","DOI":"10.15252\/embr.201338064","article-title":"sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin","volume":"15","author":"McCarthy","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1074\/jbc.REV120.008207_bib303","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s11064-019-02747-y","article-title":"Post translational modulation of beta-amyloid precursor protein trafficking to the cell surface alters neuronal iron homeostasis","volume":"44","author":"Tsatsanis","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1074\/jbc.REV120.008207_bib304","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41380-020-0762-0","article-title":"Amyloidogenic processing of Alzheimer's disease beta-amyloid precursor protein induces cellular iron retention","volume":"25","author":"Tsatsanis","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib305","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/JAD-2012-111169","article-title":"Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells","volume":"30","author":"Wan","year":"2012","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib306","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jinorgbio.2006.02.010","article-title":"Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: implications for Alzheimer beta-amyloid pathology","volume":"100","author":"Maynard","year":"2006","journal-title":"J.\u00a0Inorg. Biochem."},{"key":"10.1074\/jbc.REV120.008207_bib307","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pneurobio.2018.06.008","article-title":"The sinister face of heme oxygenase-1 in brain aging and disease","volume":"172","author":"Schipper","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1074\/jbc.REV120.008207_bib308","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0896-6273(00)00125-2","article-title":"Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease","volume":"28","author":"Takahashi","year":"2000","journal-title":"Neuron"},{"key":"10.1074\/jbc.REV120.008207_bib309","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/00002093-200000001-00011","article-title":"Interaction of amyloid precursor proteins and heme oxygenase","volume":"14 Suppl 1","author":"Takahashi","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1074\/jbc.REV120.008207_bib310","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.191351298","article-title":"Neural roles for heme oxygenase: contrasts to nitric oxide synthase","volume":"98","author":"Baranano","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib311","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s13311-015-0378-2","article-title":"Enduring elevations of hippocampal amyloid precursor protein and iron are features of beta-amyloid toxicity and are mediated by tau","volume":"12","author":"Li","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1074\/jbc.REV120.008207_bib312","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/mp.2016.96","article-title":"Lithium suppression of tau induces brain iron accumulation and neurodegeneration","volume":"22","author":"Lei","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib313","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/mp.2017.171","article-title":"Tau-mediated iron export prevents ferroptotic damage after ischemic stroke","volume":"22","author":"Tuo","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib314","first-page":"937","article-title":"Massive accumulation of modified tau and severe depletion of normal tau characterize the cerebral cortex and white matter of Alzheimer's disease. Demonstration using the hydrated autoclaving method","volume":"140","author":"Shin","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1074\/jbc.REV120.008207_bib315","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00702-009-0293-y","article-title":"Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains","volume":"116","author":"van Eersel","year":"2009","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1074\/jbc.REV120.008207_bib316","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1016\/S0021-9258(18)68426-1","article-title":"Immunochemical and biochemical characterization of tau proteins in normal and Alzheimer's disease brains with Alz 50 and Tau-1","volume":"263","author":"Ksiezak-Reding","year":"1988","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib317","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/1531-8249(20010201)49:2<165::AID-ANA36>3.0.CO;2-3","article-title":"Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia","volume":"49","author":"Zhukareva","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib318","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00401-002-0668-8","article-title":"Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study","volume":"105","author":"Zhukareva","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1074\/jbc.REV120.008207_bib319","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0014-5793(94)00829-9","article-title":"Levels of normal and abnormally phosphorylated tau in different cellular and regional compartments of Alzheimer disease and control brains","volume":"351","author":"Khatoon","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1074\/jbc.REV120.008207_bib320","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.nbd.2015.03.015","article-title":"Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse","volume":"81","author":"Lei","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1074\/jbc.REV120.008207_bib321","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1523\/JNEUROSCI.3439-13.2014","article-title":"Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging","volume":"34","author":"Ma","year":"2014","journal-title":"J.\u00a0Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib322","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2008.01.034","article-title":"Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection","volume":"434","author":"Rametti","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.REV120.008207_bib323","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2008.11.057","article-title":"Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A","volume":"1252","author":"Martin","year":"2009","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib324","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2174\/138161212799316163","article-title":"Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI\/MRS study","volume":"18","author":"Berger","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1074\/jbc.REV120.008207_bib325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044252","article-title":"The PICALM protein plays a key role in iron homeostasis and cell proliferation","volume":"7","author":"Scotland","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.REV120.008207_bib326","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-150797","article-title":"Iron regulates apolipoprotein E expression and secretion in neurons and astrocytes","volume":"51","author":"Xu","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib327","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.chembiol.2017.07.014","article-title":"Iron biochemistry is correlated with amyloid plaque morphology in an established mouse model of Alzheimer's disease","volume":"24","author":"Telling","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib328","doi-asserted-by":"crossref","first-page":"11782","DOI":"10.1039\/C7NR06794A","article-title":"Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects","volume":"10","author":"Everett","year":"2018","journal-title":"Nanoscale"},{"key":"10.1074\/jbc.REV120.008207_bib329","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","article-title":"Iron accumulation in Alzheimer disease is a source of redox-generated free radicals","volume":"94","author":"Smith","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib330","first-page":"657","article-title":"Iron is a specific cofactor for distinct oxidation- and aggregation-dependent Abeta toxicity mechanisms in a Drosophila model","volume":"8","author":"Ott","year":"2015","journal-title":"Dis. Model Mech."},{"key":"10.1074\/jbc.REV120.008207_bib331","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1006\/bbrc.1995.2678","article-title":"The role of iron in beta amyloid toxicity","volume":"216","author":"Schubert","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib332","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2005.09.013","article-title":"Redox cycling of iron by Abeta42","volume":"40","author":"Khan","year":"2006","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib333","doi-asserted-by":"crossref","first-page":"9024","DOI":"10.1021\/ic201233b","article-title":"Iron(II) binding to amyloid-beta, the Alzheimer's peptide","volume":"50","author":"Bousejra-ElGarah","year":"2011","journal-title":"Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib334","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1074\/jbc.M110.158980","article-title":"Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation","volume":"286","author":"Liu","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib335","doi-asserted-by":"crossref","first-page":"20140165","DOI":"10.1098\/rsif.2014.0165","article-title":"Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide beta-amyloid (1-42)","volume":"11","author":"Everett","year":"2014","journal-title":"J.\u00a0R. Soc. Interf."},{"key":"10.1074\/jbc.REV120.008207_bib336","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1460-9568.2009.06701.x","article-title":"Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease","volume":"29","author":"Rival","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib337","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1046\/j.1471-4159.2003.01831.x","article-title":"Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity","volume":"86","author":"Kuperstein","year":"2003","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib338","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.1021\/bi701079z","article-title":"Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron","volume":"46","author":"Nakamura","year":"2007","journal-title":"Biochemistry"},{"key":"10.1074\/jbc.REV120.008207_bib339","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.freeradbiomed.2018.11.014","article-title":"Using the synthesized peptide HAYED (5) to protect the brain against iron catalyzed radical attack in a naturally senescence Kunming mouse model","volume":"130","author":"Zou","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib340","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1016\/S0021-9258(18)53053-2","article-title":"Differences in microtubule binding and self-association abilities of bovine brain tau isoforms","volume":"268","author":"Garc\u00eda de Ancos","year":"1993","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib341","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0197-4580(95)00075-P","article-title":"Isolation of a phosphorylated soluble tau fraction from Alzheimer's disease brain","volume":"16","author":"Ledesma","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib342","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1471-4159.2002.t01-1-01061.x","article-title":"Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease","volume":"82","author":"Yamamoto","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1074\/jbc.REV120.008207_bib343","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuint.2012.05.016","article-title":"Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake","volume":"61","author":"Xie","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1074\/jbc.REV120.008207_bib344","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.neuint.2012.12.005","article-title":"Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain","volume":"62","author":"Guo","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1074\/jbc.REV120.008207_bib345","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fneur.2019.00607","article-title":"Iron deposition leads to hyperphosphorylation of tau and disruption of insulin signaling","volume":"10","author":"Wan","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib346","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0006-8993(02)03893-3","article-title":"A\u00a0novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease","volume":"961","author":"Shin","year":"2003","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib347","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41597-020-00650-8","article-title":"Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer's disease","volume":"7","author":"Ping","year":"2020","journal-title":"Sci. Data"},{"key":"10.1074\/jbc.REV120.008207_bib348","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bpa.12704","article-title":"Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP\/PS1 mice","volume":"29","author":"McIntosh","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1074\/jbc.REV120.008207_bib349","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1039\/C8MT00004B","article-title":"Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice","volume":"10","author":"Peters","year":"2018","journal-title":"Metallomics"},{"key":"10.1074\/jbc.REV120.008207_bib350","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00221-012-3101-0","article-title":"Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1alpha, and phosphorylates GSK3beta in P301L tau transgenic mice","volume":"219","author":"Fine","year":"2012","journal-title":"Exp. Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib351","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","article-title":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease","volume":"34","author":"Guo","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.REV120.008207_bib352","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fnagi.2015.00104","article-title":"Intranasal deferoxamine attenuates synapse loss via up-regulating the P38\/HIF-1alpha pathway on the brain of APP\/PS1 transgenic mice","volume":"7","author":"Guo","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib353","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.bmc.2010.12.007","article-title":"Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: iron chelators with the potential for treating Alzheimer's disease","volume":"19","author":"Gaeta","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib354","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuropharm.2017.05.026","article-title":"The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models","volume":"123","author":"Amit","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1074\/jbc.REV120.008207_bib355","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-150514","article-title":"The oral iron chelator, deferasirox, reverses the age-dependent alterations in iron and amyloid-beta homeostasis in rat brain: implications in the therapy of Alzheimer's disease","volume":"49","author":"Banerjee","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib356","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.lfs.2015.06.026","article-title":"Multi-target iron-chelators improve memory loss in a rat model of sporadic Alzheimer's disease","volume":"136","author":"Salkovic-Petrisic","year":"2015","journal-title":"Life Sci."},{"key":"10.1074\/jbc.REV120.008207_bib357","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0140-6736(91)92978-B","article-title":"Intramuscular desferrioxamine in patients with Alzheimer's disease","volume":"337","author":"Crapper McLachlan","year":"1991","journal-title":"Lancet"},{"key":"10.1074\/jbc.REV120.008207_bib358","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S1474-4422(19)30193-0","article-title":"Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegeneration","volume":"18","author":"Ayton","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib359","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1474-4422(19)30142-5","article-title":"Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study","volume":"18","author":"Klopstock","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/ars.2013.5593","article-title":"Targeting chelatable iron as a therapeutic modality in Parkinson's disease","volume":"21","author":"Devos","year":"2014","journal-title":"Antioxid. Redox Signal"},{"key":"10.1074\/jbc.REV120.008207_bib361","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41598-017-01402-2","article-title":"Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease","volume":"7","author":"Martin-Bastida","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.REV120.008207_bib362","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1074\/jbc.REV120.008207_bib363","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1074\/jbc.REV120.008207_bib364","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12031-018-1155-6","article-title":"Ferroptosis, a recent defined form of critical cell death in neurological disorders","volume":"66","author":"Wu","year":"2018","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib365","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","article-title":"The chemical basis of ferroptosis","volume":"15","author":"Conrad","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib366","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","article-title":"The hallmarks of ferroptosis","volume":"3","author":"Dixon","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1074\/jbc.REV120.008207_bib367","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","article-title":"Striking while the iron is hot: iron metabolism and ferroptosis in neurodegeneration","volume":"133","author":"Masaldan","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib368","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/mp.2016.196","article-title":"Glutathione peroxidase 4: a new player in neurodegeneration?","volume":"22","author":"Cardoso","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib369","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"10.1074\/jbc.REV120.008207_bib370","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the Crossroads of lipid homeostasis and ferroptosis","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"key":"10.1074\/jbc.REV120.008207_bib371","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10534-011-9476-8","article-title":"Glutathione: a key component of the cytoplasmic labile iron pool","volume":"24","author":"Hider","year":"2011","journal-title":"BioMetals"},{"key":"10.1074\/jbc.REV120.008207_bib372","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0021-9258(19)85901-X","article-title":"Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture","volume":"255","author":"Bannai","year":"1980","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib373","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1074\/jbc.REV120.008207_bib374","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/iub.1616","article-title":"Iron and ferroptosis: a still ill-defined liaison","volume":"69","author":"Doll","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1074\/jbc.REV120.008207_bib375","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1074\/jbc.REV120.008207_bib376","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","article-title":"Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture","volume":"22","author":"Riegman","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1074\/jbc.REV120.008207_bib377","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.chembiol.2020.03.007","article-title":"The chemical biology of ferroptosis in the central nervous system","volume":"27","author":"Ratan","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib378","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/cas.13380","article-title":"Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3","volume":"108","author":"Shintoku","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1074\/jbc.REV120.008207_bib379","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.56580","article-title":"Changes in ferrous iron and glutathione promote ferroptosis and frailty in aging Caenorhabditis elegans","volume":"9","author":"Jenkins","year":"2020","journal-title":"Elife"},{"key":"10.1074\/jbc.REV120.008207_bib380","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0891-5849(02)01360-6","article-title":"The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults","volume":"34","author":"Yant","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib381","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0006-291X(03)00734-4","article-title":"Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene","volume":"305","author":"Imai","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1074\/jbc.REV120.008207_bib382","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","article-title":"Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death","volume":"8","author":"Seiler","year":"2008","journal-title":"Cell Metab."},{"key":"10.1074\/jbc.REV120.008207_bib383","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.freeradbiomed.2012.02.043","article-title":"Gpx4 ablation in adult mice results in a lethal phenotype accompanied by neuronal loss in brain","volume":"52","author":"Yoo","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib384","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.redox.2017.01.021","article-title":"Ablation of ferroptosis regulator glutathione peroxidase 4 in forebrain neurons promotes cognitive impairment and neurodegeneration","volume":"12","author":"Hambright","year":"2017","journal-title":"Redox Biol."},{"key":"10.1074\/jbc.REV120.008207_bib385","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/NEN.0b013e3181cb5af4","article-title":"Oxidative stress in the progression of Alzheimer disease in the frontal cortex","volume":"69","author":"Ansari","year":"2010","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib386","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.biopsych.2015.04.005","article-title":"Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease","volume":"78","author":"Mandal","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1074\/jbc.REV120.008207_bib387","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/hbm.24799","article-title":"Quantitation of in\u00a0vivo brain glutathione conformers in cingulate cortex among age-matched control, MCI, and AD patients using MEGA-PRESS","volume":"41","author":"Shukla","year":"2020","journal-title":"Hum. Brain Mapp."},{"key":"10.1074\/jbc.REV120.008207_bib388","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-2007-11113","article-title":"Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease","volume":"11","author":"Jacob","year":"2007","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib389","doi-asserted-by":"crossref","first-page":"101494","DOI":"10.1016\/j.redox.2020.101494","article-title":"Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine\/glutamate antiporter in Alzheimer's disease: evidence of ferroptosis","volume":"32","author":"Ashraf","year":"2020","journal-title":"Redox Biol."},{"key":"10.1074\/jbc.REV120.008207_bib390","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1039\/C7FO02063E","article-title":"Comparison of the effects of selenomethionine and selenium-enriched yeast in the triple-transgenic mouse model of Alzheimer's disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Food Funct."},{"key":"10.1074\/jbc.REV120.008207_bib391","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/acel.12216","article-title":"Relative importance of redox buffers GSH and NAD(P)H in age-related neurodegeneration and Alzheimer disease-like mouse neurons","volume":"13","author":"Ghosh","year":"2014","journal-title":"Aging Cell"},{"key":"10.1074\/jbc.REV120.008207_bib392","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1089\/ars.2009.2891","article-title":"Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease","volume":"12","author":"Yoo","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1074\/jbc.REV120.008207_bib393","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainres.2006.06.042","article-title":"Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice","volume":"1109","author":"Fu","year":"2006","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib394","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1212\/WNL.57.8.1515","article-title":"Controlled trial of N-acetylcysteine for patients with probable Alzheimer's disease","volume":"57","author":"Adair","year":"2001","journal-title":"Neurology"},{"key":"10.1074\/jbc.REV120.008207_bib395","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.redox.2017.11.001","article-title":"alpha-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice","volume":"14","author":"Zhang","year":"2018","journal-title":"Redox Biol."},{"key":"10.1074\/jbc.REV120.008207_bib396","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10571-009-9461-8","article-title":"Alpha-tocopherol decreases iron-induced hippocampal and nigral neuron loss","volume":"30","author":"Bostanci","year":"2010","journal-title":"Cell Mol. Neurobiol."},{"key":"10.1074\/jbc.REV120.008207_bib397","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2013.282834","article-title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial","volume":"311","author":"Dysken","year":"2014","journal-title":"JAMA"},{"key":"10.1074\/jbc.REV120.008207_bib398","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2019.03.032","article-title":"Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke","volume":"177","author":"Alim","year":"2019","journal-title":"Cell"},{"key":"10.1074\/jbc.REV120.008207_bib399","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1017\/S0007114509992832","article-title":"Nutritional status of selenium in Alzheimer's disease patients","volume":"103","author":"Cardoso","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1074\/jbc.REV120.008207_bib400","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3233\/JAD-131892","article-title":"Differences in nutritional status between very mild Alzheimer's disease patients and healthy controls","volume":"41","author":"Olde Rikkert","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib401","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-160622","article-title":"Selenium levels in serum, red blood cells, and cerebrospinal fluid of Alzheimer's disease patients: a report from the Australian Imaging, Biomarker & Lifestyle Flagship study of ageing (AIBL)","volume":"57","author":"Cardoso","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib402","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1021\/acschemneuro.7b00014","article-title":"The APOE epsilon4 allele is associated with lower selenium levels in the brain: implications for Alzheimer's disease","volume":"8","author":"B","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib403","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12011-018-1492-x","article-title":"Brain selenium in Alzheimer's disease (BRAIN SEAD study): a systematic review and meta-analysis","volume":"189","author":"Varikasuvu","year":"2019","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1074\/jbc.REV120.008207_bib404","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2009.04.010","article-title":"Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type","volume":"1281","author":"Ishrat","year":"2009","journal-title":"Brain Res."},{"key":"10.1074\/jbc.REV120.008207_bib405","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neulet.2009.12.035","article-title":"Selenium attenuates A beta production and A beta-induced neuronal death","volume":"469","author":"Gwon","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1074\/jbc.REV120.008207_bib406","first-page":"91","article-title":"ERK activation induced by selenium treatment significantly downregulates beta\/gamma-secretase activity and Tau phosphorylation in the transgenic rat overexpressing human selenoprotein M","volume":"24","author":"Yim","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"10.1074\/jbc.REV120.008207_bib407","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1039\/C6MT00117C","article-title":"Selenomethionine reduces the deposition of beta-amyloid plaques by modulating beta-secretase and enhancing selenoenzymatic activity in a mouse model of Alzheimer's disease","volume":"8","author":"Zhang","year":"2016","journal-title":"Metallomics"},{"key":"10.1074\/jbc.REV120.008207_bib408","doi-asserted-by":"crossref","first-page":"39290","DOI":"10.1038\/srep39290","article-title":"Sodium selenate regulates the brain ionome in a transgenic mouse model of Alzheimer's disease","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1074\/jbc.REV120.008207_bib409","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00775-017-1463-2","article-title":"Ebselen ameliorates beta-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice","volume":"22","author":"Xie","year":"2017","journal-title":"J.\u00a0Biol. Inorg. Chem."},{"key":"10.1074\/jbc.REV120.008207_bib410","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1021\/acschemneuro.8b00034","article-title":"Effect of sodium selenate on hippocampal proteome of 3xTg-AD mice-exploring the antioxidant dogma of selenium against Alzheimer's disease","volume":"9","author":"Iqbal","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib411","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1039\/c3mt00035d","article-title":"Elevated amyloid-beta plaque deposition in dietary selenium-deficient Tg2576 transgenic mice","volume":"5","author":"Haratake","year":"2013","journal-title":"Metallomics"},{"key":"10.1074\/jbc.REV120.008207_bib412","doi-asserted-by":"crossref","first-page":"13888","DOI":"10.1073\/pnas.1009038107","article-title":"Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models","volume":"107","author":"van Eersel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1074\/jbc.REV120.008207_bib413","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.jocn.2010.04.020","article-title":"Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model","volume":"17","author":"Corcoran","year":"2010","journal-title":"J.\u00a0Clin. Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib414","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2017.07.006","article-title":"Sodium selenate activated Wnt\/beta-catenin signaling and repressed amyloid-beta formation in a triple transgenic mouse model of Alzheimer's disease","volume":"297","author":"Jin","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib415","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JAD-131805","article-title":"Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease","volume":"41","author":"Song","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib416","doi-asserted-by":"crossref","first-page":"749","DOI":"10.3233\/JAD-151208","article-title":"Selenoprotein S reduces endoplasmic reticulum stress-induced phosphorylation of tau: potential role in selenate mitigation of tau pathology","volume":"55","author":"Rueli","year":"2017","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib417","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-160544","article-title":"A\u00a0phase IIa randomized control trial of VEL015 (sodium selenate) in mild-moderate Alzheimer's disease","volume":"54","author":"Malpas","year":"2016","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1074\/jbc.REV120.008207_bib418","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s13311-018-0662-z","article-title":"Supranutritional sodium selenate supplementation delivers selenium to the central nervous system: results from a randomized controlled pilot trial in Alzheimer's disease","volume":"16","author":"Cardoso","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1074\/jbc.REV120.008207_bib419","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s12603-013-0004-0","article-title":"A\u00a0randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial","volume":"17","author":"Kryscio","year":"2013","journal-title":"J.\u00a0Nutr. Health Aging"},{"key":"10.1074\/jbc.REV120.008207_bib420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/alzrt224","article-title":"The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease","volume":"5","author":"Shah","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1074\/jbc.REV120.008207_bib421","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13195-015-0134-1","article-title":"Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease","volume":"7","author":"Rijpma","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1074\/jbc.REV120.008207_bib422","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamaneurol.2016.5778","article-title":"Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADViSE)","volume":"74","author":"Kryscio","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1074\/jbc.REV120.008207_bib423","first-page":"146","article-title":"Uber eine eigenartige Erkrankung der Hirnrinde","volume":"64","author":"Alzheimer","year":"1907","journal-title":"Allg. Z. Psychiatr."},{"key":"10.1074\/jbc.REV120.008207_bib424","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1367-5931(99)00073-3","article-title":"Metals and neuroscience","volume":"4","author":"Bush","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib425","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer's disease","volume":"26","author":"Bush","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1074\/jbc.REV120.008207_bib426","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cbpa.2008.02.019","article-title":"Metals in Alzheimer's and Parkinson's diseases","volume":"12","author":"Barnham","year":"2008","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1074\/jbc.REV120.008207_bib427","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13311-014-0312-z","article-title":"Biometals and their therapeutic implications in Alzheimer's disease","volume":"12","author":"Ayton","year":"2015","journal-title":"Neurotherapeutics"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.REV120.008207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T20:30:12Z","timestamp":1723926612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":427,"alternative-id":["S0021925820000952"],"URL":"https:\/\/doi.org\/10.1074\/jbc.rev120.008207","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The essential elements of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.REV120.008207","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100105"}}